Literature DB >> 35230474

Increased vitreous levels of B cell activation factor (BAFF) and soluble interleukin-6 receptor in patients with macular edema due to uveitis related to Behçet's disease and sarcoidosis.

Atsunobu Takeda1, Eiichi Hasegawa2, Nobuyo Yawata2,3, Shoji Notomi2, Keijiro Ishikawa2, Yusuke Murakami2, Toshio Hisatomi4, Kazuhiro Kimura5, Koh-Hei Sonoda2,3.   

Abstract

PURPOSE: Uveitis accounts for 10-15% of all cases of blindness in the developed world. Uveitic macular edema (UME) is a primary cause of permanent visual impairment in patients with uveitis. Because proinflammatory mediators elicit inflammation and lead to UME, we determined the profiles of proinflammatory mediators associated with complications, such as ME, in the vitreous humor of patients with panuveitis related to Behçet's disease (BD) and sarcoidosis.
METHODS: In this retrospective study, we enrolled 21 patients with uveitis, including 6 with BD and 15 with sarcoidosis, and 15 patients with idiopathic epiretinal membrane (iERM) at the Department of Ophthalmology, Kyushu University Hospital, between January 2008 and April 2016. Vitreous concentrations of 32 proinflammatory mediators, including cytokines and soluble receptors of tumor necrosis factor (TNF) and interleukin (IL)-6 families, were assessed using a bead-based multiplex assay and their association with clinical data was examined.
RESULTS: The levels of proinflammatory mediators, including a proliferation-inducing ligand (APRIL), B cell activating factor belonging to the TNF family (BAFF), soluble cluster of differentiation 30 (sCD30), soluble TNF receptor-1 (sTNFR1), sTNFR2, TNF-α, IL-6, and soluble IL-6 receptor-α (sIL-6Rα), were significantly higher in patients with uveitis. With regard to clinical parameters in patients with uveitis, vitreous levels of BAFF and sIL-6Rα were prominently elevated in patients with UME compared to in those without UME (P < 0.01, respectively).
CONCLUSIONS: Our results suggest that elevated vitreous levels of BAFF and sIL-6Rα are associated with the pathogenesis of UME in patients with panuveitis related to BD and sarcoidosis.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  BAFF; Cytokine; Macular edema; Soluble IL-6 receptor; Uveitis

Mesh:

Substances:

Year:  2022        PMID: 35230474     DOI: 10.1007/s00417-022-05600-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  35 in total

Review 1.  New therapies in development for the management of non-infectious uveitis: A review.

Authors:  Muhammad Hassan; Samendra Karkhur; Jeong H Bae; Muhammad S Halim; Maria S Ormaechea; Neil Onghanseng; Nam V Nguyen; Rubbia Afridi; Yasir J Sepah; Diana V Do; Quan D Nguyen
Journal:  Clin Exp Ophthalmol       Date:  2019-04       Impact factor: 4.207

2.  Impact of macular edema on visual acuity in uveitis.

Authors:  Charlotte W T A Lardenoye; Bram van Kooij; Aniki Rothova
Journal:  Ophthalmology       Date:  2006-08       Impact factor: 12.079

3.  Distinct cytokine and chemokine profiles in the aqueous of patients with uveitis and cystoid macular edema.

Authors:  Bram van Kooij; Aniki Rothova; Ger T Rijkers; Jolanda D F de Groot-Mijnes
Journal:  Am J Ophthalmol       Date:  2006-07       Impact factor: 5.258

4.  Risk of Ocular Complications in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.

Authors:  Andrew D Dick; Namita Tundia; Rachael Sorg; Chen Zhao; Jingdong Chao; Avani Joshi; Martha Skup
Journal:  Ophthalmology       Date:  2015-12-19       Impact factor: 12.079

5.  Epidemiology of Macular Edema in Uveitis.

Authors:  Massimo Accorinti; Annabelle A Okada; Justine R Smith; Marta Gilardi
Journal:  Ocul Immunol Inflamm       Date:  2019-03-01       Impact factor: 3.070

6.  Degree, duration, and causes of visual loss in uveitis.

Authors:  O M Durrani; N N Tehrani; J E Marr; P Moradi; P Stavrou; P I Murray
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

7.  Systematic correlation of morphologic alterations and retinal function in eyes with uveitis-associated cystoid macular oedema during development, resolution and relapse.

Authors:  Marion R Munk; Christopher G Kiss; Irene Steiner; Florian Sulzbacher; Phillipp Roberts; Maria Kroh; Alessio Montuoro; Christian Simader; Ursula Schmidt-Erfurth
Journal:  Br J Ophthalmol       Date:  2013-08-02       Impact factor: 4.638

8.  Intraocular and serum cytokine profiles in patients with intermediate uveitis.

Authors:  Natasa Vidovic Valentincic; Jolanda D F de Groot-Mijnes; Aleksandra Kraut; Peter Korosec; Marko Hawlina; Aniki Rothova
Journal:  Mol Vis       Date:  2011-07-20       Impact factor: 2.367

Review 9.  New Insights Into Immunological Therapy for Retinal Disorders.

Authors:  Atsunobu Takeda; Ryoji Yanai; Yusuke Murakami; Mitsuru Arima; Koh-Hei Sonoda
Journal:  Front Immunol       Date:  2020-07-03       Impact factor: 7.561

Review 10.  Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges.

Authors:  Horace Massa; Spyros Y Pipis; Georgios D Panos; Temilade Adewoyin; Athanasios Vergados; Sudeshna Patra
Journal:  Clin Ophthalmol       Date:  2019-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.